86 related articles for article (PubMed ID: 1384546)
1. HLA class I binding regions of HIV-1 proteins.
Choppin J; Guillet JG; Lévy JP
Crit Rev Immunol; 1992; 12(1-2):1-16. PubMed ID: 1384546
[TBL] [Abstract][Full Text] [Related]
2. HLA-binding regions of HIV-1 proteins. II. A systematic study of viral proteins.
Choppin J; Martinon F; Connan F; Pauchard M; Gomard E; Levy JP
J Immunol; 1991 Jul; 147(2):575-83. PubMed ID: 1712812
[TBL] [Abstract][Full Text] [Related]
3. HLA-binding regions of HIV-1 proteins. I. Detection of seven HLA binding regions in the HIV-1 Nef protein.
Choppin J; Martinon F; Connan F; Gomard E; Levy JP
J Immunol; 1991 Jul; 147(2):569-74. PubMed ID: 1712811
[TBL] [Abstract][Full Text] [Related]
4. Induction of a primary human cytotoxic T-lymphocyte response against a novel conserved epitope in a functional sequence of HIV-1 reverse transcriptase.
van der Burg SH; Klein MR; van de Velde CJ; Kast WM; Miedema F; Melief CJ
AIDS; 1995 Feb; 9(2):121-7. PubMed ID: 7536421
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of multiple HLA-A24-restricted HIV-1 CTL epitopes: strong epitopes are derived from V regions of HIV-1.
Ikeda-Moore Y; Tomiyama H; Miwa K; Oka S; Iwamoto A; Kaneko Y; Takiguchi M
J Immunol; 1997 Dec; 159(12):6242-52. PubMed ID: 9550428
[TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization.
Sandberg JK; Leandersson AC; Devito C; Kohleisen B; Erfle V; Achour A; Levi M; Schwartz S; Kärre K; Wahren B; Hinkula J
Virology; 2000 Jul; 273(1):112-9. PubMed ID: 10891413
[TBL] [Abstract][Full Text] [Related]
7. HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs.
DiBrino M; Tsuchida T; Turner RV; Parker KC; Coligan JE; Biddison WE
J Immunol; 1993 Dec; 151(11):5930-5. PubMed ID: 7504010
[TBL] [Abstract][Full Text] [Related]
8. Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection.
Borghan MA; Oka S; Takiguchi M
Tissue Antigens; 2005 Oct; 66(4):305-13. PubMed ID: 16185326
[TBL] [Abstract][Full Text] [Related]
9. Evidence of presentation of multiple HIV-1 cytotoxic T lymphocyte epitopes by HLA-B*3501 molecules that are associated with the accelerated progression of AIDS.
Tomiyama H; Miwa K; Shiga H; Moore YI; Oka S; Iwamoto A; Kaneko Y; Takiguchi M
J Immunol; 1997 May; 158(10):5026-34. PubMed ID: 9144523
[TBL] [Abstract][Full Text] [Related]
10. Selective in vitro expansion of HLA class I-restricted HIV-1 Gag-specific CD8+ T cells: cytotoxic T-lymphocyte epitopes and precursor frequencies.
van Baalen CA; Klein MR; Geretti AM; Keet RI; Miedema F; van Els CA; Osterhaus AD
AIDS; 1993 Jun; 7(6):781-6. PubMed ID: 7689847
[TBL] [Abstract][Full Text] [Related]
11. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
Nayersina R; Fowler P; Guilhot S; Missale G; Cerny A; Schlicht HJ; Vitiello A; Chesnut R; Person JL; Redeker AG; Chisari FV
J Immunol; 1993 May; 150(10):4659-71. PubMed ID: 7683326
[TBL] [Abstract][Full Text] [Related]
12. Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes.
Ishioka GY; Fikes J; Hermanson G; Livingston B; Crimi C; Qin M; del Guercio MF; Oseroff C; Dahlberg C; Alexander J; Chesnut RW; Sette A
J Immunol; 1999 Apr; 162(7):3915-25. PubMed ID: 10201910
[TBL] [Abstract][Full Text] [Related]
13. Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual.
Harrer T; Harrer E; Barbosa P; Kaufmann F; Wagner R; Brüggemann S; Kalden JR; Feinberg M; Johnson RP; Buchbinder S; Walker BD
J Immunol; 1998 Nov; 161(9):4875-81. PubMed ID: 9794421
[TBL] [Abstract][Full Text] [Related]
14. HLA-A2-restricted cytotoxic T lymphocyte responses to multiple Plasmodium falciparum sporozoite surface protein 2 epitopes in sporozoite-immunized volunteers.
Wizel B; Houghten R; Church P; Tine JA; Lanar DE; Gordon DM; Ballou WR; Sette A; Hoffman SL
J Immunol; 1995 Jul; 155(2):766-75. PubMed ID: 7541824
[TBL] [Abstract][Full Text] [Related]
15. CTLs from lymphoid organs recognize an optimal HLA-A2-restricted and HLA-B52-restricted nonapeptide and several epitopes in the C-terminal region of HIV-1 Nef.
Hadida F; Haas G; Zimmermann N; Hosmalin A; Spohn R; Samri A; Jung G; Debre P; Autran B
J Immunol; 1995 Apr; 154(8):4174-86. PubMed ID: 7535824
[TBL] [Abstract][Full Text] [Related]
16. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1.
Shirai M; Arichi T; Nishioka M; Nomura T; Ikeda K; Kawanishi K; Engelhard VH; Feinstone SM; Berzofsky JA
J Immunol; 1995 Mar; 154(6):2733-42. PubMed ID: 7533182
[TBL] [Abstract][Full Text] [Related]
17. Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins.
Kast WM; Brandt RM; Sidney J; Drijfhout JW; Kubo RT; Grey HM; Melief CJ; Sette A
J Immunol; 1994 Apr; 152(8):3904-12. PubMed ID: 7511661
[TBL] [Abstract][Full Text] [Related]
18. Conserved CTL epitopes shared between HIV-infected human long-term survivors and chimpanzees.
Balla-Jhagjhoorsingh SS; Koopman G; Mooij P; Haaksma TG; Teeuwsen VJ; Bontrop RE; Heeney JL
J Immunol; 1999 Feb; 162(4):2308-14. PubMed ID: 9973508
[TBL] [Abstract][Full Text] [Related]
19. Epitope recognition of conserved HIV envelope sequences by human cytotoxic T lymphocytes.
Dadaglio G; Leroux A; Langlade-Demoyen P; Bahraoui EM; Traincard F; Fisher R; Plata F
J Immunol; 1991 Oct; 147(7):2302-9. PubMed ID: 1717555
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cell vaccination induces cross-reactive cytotoxic T lymphocytes specific for wild-type and natural variant human immunodeficiency virus type 1 epitopes in HLA-A*0201/Kb transgenic mice.
Abdel-Motal UM; Friedline R; Poligone B; Pogue-Caley RR; Frelinger JA; Tisch R
Clin Immunol; 2001 Oct; 101(1):51-8. PubMed ID: 11580226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
